A new sepsis treatment has been found to
have an increased effectiveness in January 2003. The sepsis
treatment is the first biologic treatment approved for sepsis and
is in clinical practice and so far has proven to be safe and effective.
Called drotrecogin alfa, the new sepsis treatment is a genetically
engineered version of a naturally occurring human protein that interferes
with some of the body’s harmful responses to severe infection.
Sepsis is a life-threatening condition and when
it affects elders, the lowered level of immunity they may have can
prevent healing from occurring, so the search for an effective sepsis
treatment has been sought after for quite awhile. The problem with
finding a successful sepsis treatment has been that the results
of different sepsis treatment options vary widely amongst patients
depending on the stage and severity of the sepsis. In some patients
with an advanced stage of sepsis using one type of sepsis treatment
can help them but hurt other sepsis patients that may have a more
minor condition. Finding a sepsis treatment should be individually
decided and trying to tailor one particular sepsis treatment to
all patients has been found to do more harm than good.